Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the research-grade proteins market grown over the years?

The market size of research-grade proteins has seen a significant expansion in recent years. Its growth is projected to increase from $1.11 billion in 2024 to $1.35 billion in 2025, with a compound annual growth rate (CAGR) of 21.4%. Factors contributing to this growth during the historic period include the escalation of research activities, an upward trend in R&D endeavors in the pharmaceutical and biotechnology sectors, growing interest in personalized medicine, amplified government and academic institute investments, and judicious acquisitions and partnerships.

What Is the forecasted market size and growth rate for the research-grade proteins market?

The research-grade proteins market size is expected to see exponential growth in the next few years. It will grow to $2.9 billion in 2029 at a compound annual growth rate (CAGR) of 21.2%. The growth in the forecast period can be attributed to advancements in proteomics research, growing number of clinical trials, integration of AI and data analytics, use of research-grade proteins in industrial applications and rising demand for advanced research tools. Major trends in the forecast period include growing awareness of innovative technologies, technological advancements in the biotechnology industry, advancements in proteomics and genomics, expanding applications in drug development and advanced research tools in the fields of biotechnology and pharmaceuticals.

Get your research-grade proteins market report here!

https://www.thebusinessresearchcompany.com/report/research-grade-proteins-global-market-report

What are the major factors driving growth in the research-grade proteins market?

The surge in clinical trials is anticipated to fuel the expansion of the research-grade proteins market. Clinical trials, which are research studies that explore the safety and efficacy of novel medical treatments, interventions, or devices in humans, are on the increase due to advancements in medical research, disease prevalence, regulatory shifts, patient needs, and industry investment. Research-grade proteins contribute to clinical trials as crucial components for the development of biomarkers, the creation of assays, the identification of drug targets, quality management, and reference standards, ensuring experimental data’s accuracy and dependability. For example, ClinicalTrials.gov, a clinical trial registry based in the United States, reported that by the end of 2023, the number of registered clinical trials worldwide on ClinicalTrials.gov was 477,234, a rise from the 437,512 clinical trials registered in 2022. Therefore, the escalating number of clinical trials is propelling the growth of the research-grade proteins market.

What key areas define the segmentation of the global research-grade proteins Market?

The research-grade proteins market covered in this report is segmented –

1) By Product: Cytokines And Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones, Other Products

2) By Host Cell: Mammalian Cells, Bacterial Cells, Fungi And Yeast, Insect Cells, Other Host Cells

3) By End-Use: Pharmaceutical And Biotechnology Companies, Academic And Research Institute, Other End-Uses

Subsegments:

1) By Cytokines And Growth Factors: Interleukins, Interferons, Colony Stimulating Factors, Erythropoietin, Granulocyte Macrophage Colony-Stimulating Factor

2) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Conjugated Antibodies

3) By Immune Checkpoint Proteins: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors

4) By Virus Antigens: HIV Antigens, Hepatitis Antigens, Influenza Antigens, Hepatitis B Antigens

5) By Enzymes: Restriction Enzymes, Proteases, Ligases, Kinases

6) By Recombinant Regulatory Proteins: Transcription Factors, Regulatory Enzymes, Epigenetic Modifiers

7) By Hormones: Insulin, Thyroid Hormones, Growth Hormones, Adrenaline

8) By Other Products: Peptides, Serum Proteins, Antigen-Binding Proteins

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15917&type=smp

Who are the key firms paving the way for growth in the research-grade proteins market?

Major companies operating in the research-grade proteins market are Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Bio-Techne, Stemcell Technologies Inc., Miltenyi Biotec, GenScript Biotech Corporation, Sino Biological Inc., ACROBiosystems, OriGene Technologies Inc., RayBiotech Inc., Rockland Immunochemicals Inc., Proteintech Group Inc., Novus Biologicals LLC, Active Motif, Aviva Systems Biology Corporation, StressMarq Biosciences Inc., Abnova Corporation, AnaSpec, Biomatik, Prospec-Tany Technogene Ltd., Cusabio Technology LLC, United States Biological, Laurus Bio, Boster Biological Technology, AMS Biotechnology Europe Ltd (AMSBIO)

What are the key trends shaping the future of the research-grade proteins market?

Major businesses in the research-grade proteins industry are innovating by creating Cas9 proteins, which have broad applications in biotechnology, particularly in genome editing. Cas9 proteins perform the function of molecular scissors which can slice DNA at particular points as guided by a guide RNA (gRNA). For example, in April 2022, the American biotechnology firm Thermo Fisher Scientific Inc. launched an advanced GMP-produced Gibco CTS TrueCut Cas9 Protein. This top-tier, clinically compatible Cas9 protein is manufactured under Good Manufacturing Practice (GMP) guidelines. It is bespoke designed for genome editing applications and provides high purity and functionality, specifically intended for precise CRISPR-based research. This product will help bring progress in genetic engineering and the development of therapeutics.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15917

Which regions are emerging as leaders in the research-grade proteins market?

North America was the largest region in the research-grade proteins market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the research-grade proteins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Textured Pea Protein Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/textured-pea-protein-global-market-report

Textured Soy Protein Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/textured-soy-protein-global-market-report

C-Reactive Protein Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: